United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of the business's stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $547.50, for a total value of $5,475,000.00. Following the transaction, the chief financial officer owned 18,876 shares in the company, valued at approximately $10,334,610. This represents a 34.63% decrease in their position. The sale was d…